Faith L. Charles insider trades: CNS Pharmaceuticals (CNSP) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Faith reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 18, 2026 | CNSP | ↑ Buy | 7,100 | $4.79 | $34K | Direct | May 20, 2026 (2d) |
| Jul 9, 2025 | ABEO | ↓ Sell | 10,738 | $5.86 | $63K | Direct | Jul 10, 2025 (1d) |
| Apr 26, 2024 | ABEO | ↑ Buy | 7,550 | $3.28 | $25K | Direct | Apr 29, 2024 (3d) |
| Sep 27, 2023 | ABEO | ↓ Sell | 8,330 | $4.91 | $41K | Direct | Sep 29, 2023 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other CNSP insiders
Open-market trades in the last 12 months
About Faith L. Charles's insider trades
Faith L. Charles is a director at CNS Pharmaceuticals (CNSP). Since Sep 27, 2023, Faith has reported 2 open-market purchases worth $59K and 2 sales worth $104K on SEC Form 4. In the last 12 months: 1 buy ($34K).
Their filings also include grants and awards (18 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CNSP insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.